Target intelligence / Profile preview

Candida albicans cell membrane (None in common usage)

Target
None in common usage
Molecular classification
Other (it is a biological membrane, not a protein, enzyme, or receptor), Lipid bilayer (contains ergosterol, phospholipids, and membrane-associated proteins)
01

Overview

The Candida albicans cell membrane is a lipid bilayer embedded with proteins, crucial for maintaining homeostasis, mediating nutrient transport, and serving as a scaffold for enzymes involved in cell wall synthesis. This membrane is biochemically distinct from human cell membranes due to the presence of ergosterol, making it an attractive target for antifungal drugs. Disruption of the cell membrane results in loss of osmotic control and cell death, which is exploited by polyenes and azoles. Resistance mechanisms include changes in membrane lipid composition, upregulation of efflux pumps, and altered ergosterol biosynthetic pathways[3][9]. The membrane operates in close concert with the cell wall, and its integrity is essential for virulence, biofilm formation, and drug susceptibility in Candida albicans[3][4][9].

Other names
Candida albicans plasma membrane
02

Mechanism of action

Azoles: Inhibit lanosterol 14-α-demethylase, blocking ergosterol synthesis, leading to increased membrane permeability[9]; Polyenes: Bind directly to ergosterol, forming pores in the membrane that cause leakage of cell contents and cell death[8][9]

03

Biological functions

Osmotic and structural barrierRegulates transport of ions, nutrients, and metabolitesHouses membrane proteins, enzymes, and channelsMaintains cell integritySignal transduction
04

Disease associations

Infection (mainly candidiasis)Antifungal drug target
05

Safety considerations

Amphotericin B: Nephrotoxicity due to binding of host cholesterol at high doses[9]Azoles: Hepatotoxicity, drug–drug interactions[3]Drug resistance: Membrane composition mutations causing reduced drug binding or uptake[3]
06

Interacting drugs

Azoles (e.g., fluconazole, itraconazole) [inhibit ergosterol biosynthesis][9]

2 more in the full profile.

07

Biomarkers

Ergosterol concentration (used to monitor fungal burden and effectiveness of ergosterol-targeting drugs)[9]

Beyond the preview

Go deeper on Candida albicans cell membrane (None in common usage).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida albicans cell membrane (None in common usage).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call